Passive Immunization Against Dental Caries and Periodontal Disease: Development of Recombinant and Human Monoclonal Antibodies
Author:
Open Access
- 1 April 2000
- journal article
- other
- Published by SAGE Publications in Critical Reviews in Oral Biology & Medicine
- Vol. 11 (2) , 140-158
Abstract
Indigenous micro-organisms in the oral cavity can cause two major diseases, dental caries and periodontal diseases. There is neither agreement nor consensus as to the actual mechanisms of pathogenesis of the specific virulence factors of these micro-organisms. The complexity of the bacterial community in dental plaque has made it difficult for the single bacterial agent of dental caries to be determined. However, there is considerable evidence that Streptococcus mutans is implicated as the primary causative organism of dental caries, and the cell-surface protein antigen (SA I/II) as well as glucosyltransferases (GTFs) produced by S. mutans appear to be major colonization factors. Various forms of periodontal diseases are closely associated with specific subgingival bacteria. Porphyromonas gingivalis has been implicated as an important etiological agent of adult periodontitis. Adherence of bacteria to host tissues is a prerequisite for colonization and one of the important steps in the disease process. Bacterial coaggregation factors and hemagglutinins likely play major roles in colonization in the subgingival area. Emerging evidence suggests that inhibition of these virulence factors may protect the host against caries and periodontal disease. Active and passive immunization approaches have been developed for immunotherapy of these diseases. Recent advances in mucosal immunology and the introduction of novel strategies for inducing mucosal immune responses now raise the possibility that effective and safe vaccines can be constructed. In this regard, some successful results have been reported in animal experimental models. Nevertheless, since the public at large might be skeptical about the seriousness of oral diseases, immunotherapy must be carried out with absolute safety. For this goal to be achieved, the development of safe antibodies for passive immunization is significant and important. In this review, salient advances in passive immunization against caries and periodontal diseases are summarized, and the biotechnological approaches for developing recombinant and human-type antibodies are introduced. Furthermore, our own attempts to construct single-chain variable fragments (ScFv) and human-type antibodies capable of neutralizing virulence factors are discussed.Keywords
This publication has 153 references indexed in Scilit:
- Mice perform a human repertoireNature, 1997
- Duplication and differential expression of hemagglutinin genes in Porphyromonas gingivalisOral Microbiology and Immunology, 1996
- The cloning, expression and sequence analysis of a second Porphyromonas gingivalis gene that codes for a protein involved in hemagglutinationOral Microbiology and Immunology, 1995
- Modification of experimental Porphyromonas gingivalis murine infection by immunization with a polysaccharide‐protein conjugateOral Microbiology and Immunology, 1993
- Large-scale fermentation and purification of a recombinant protein from Escherichia coliProcess Biochemistry, 1991
- Characterization of Porphyromonas (bacteroides) gingivalis hemagglutinin as a proteaseBiochemical and Biophysical Research Communications, 1991
- Phage antibodies: filamentous phage displaying antibody variable domainsNature, 1990
- Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coliNature, 1989
- The stimulation of macrophage prostaglandin E2 and thromboxane B2 secretion by Streptococcus mutans insoluble glucansFEBS Letters, 1983
- Resolution of Streptococcus mutans glucosyltransferases into two components essential to water‐insoluble glucan synthesisFEBS Letters, 1981